ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 219 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,471 | +4.3% | 3,080 | 0.0% | 0.01% | +20.0% |
Q2 2023 | $38,808 | -3.4% | 3,080 | 0.0% | 0.01% | -16.7% |
Q1 2023 | $40,194 | -26.0% | 3,080 | 0.0% | 0.01% | -33.3% |
Q4 2022 | $54,331 | +15.6% | 3,080 | 0.0% | 0.01% | -10.0% |
Q3 2022 | $47,000 | +2.2% | 3,080 | 0.0% | 0.01% | +11.1% |
Q2 2022 | $46,000 | -33.3% | 3,080 | 0.0% | 0.01% | -30.8% |
Q1 2022 | $69,000 | +21.1% | 3,080 | 0.0% | 0.01% | +18.2% |
Q4 2021 | $57,000 | +39.0% | 3,080 | 0.0% | 0.01% | +22.2% |
Q3 2021 | $41,000 | -28.1% | 3,080 | 0.0% | 0.01% | -25.0% |
Q2 2021 | $57,000 | +23.9% | 3,080 | 0.0% | 0.01% | +20.0% |
Q1 2021 | $46,000 | +4.5% | 3,080 | 0.0% | 0.01% | -9.1% |
Q4 2020 | $44,000 | +76.0% | 3,080 | 0.0% | 0.01% | +37.5% |
Q3 2020 | $25,000 | +25.0% | 3,080 | 0.0% | 0.01% | +14.3% |
Q2 2020 | $20,000 | -9.1% | 3,080 | 0.0% | 0.01% | -22.2% |
Q1 2020 | $22,000 | -26.7% | 3,080 | 0.0% | 0.01% | -40.0% |
Q4 2019 | $30,000 | – | 3,080 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 1,500,000 | $21,593,000 | 4.50% |
KESTREL INVESTMENT MANAGEMENT CORP | 445,500 | $6,433,000 | 3.14% |
Adirondack Research & Management Inc. | 155,088 | $2,239,000 | 3.06% |
SHAPIRO CAPITAL MANAGEMENT LLC | 9,398,617 | $135,716,029,000 | 2.92% |
Waterfront Wealth Inc. | 136,976 | $1,978,000 | 1.40% |
Smith, Graham & Co., Investment Advisors, LP | 1,008,283 | $14,560,000 | 1.34% |
S&T BANK/PA | 475,184 | $6,862,000 | 1.23% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,132,500 | $16,354,000 | 0.98% |
HENNESSY ADVISORS INC | 1,024,100 | $14,788,000 | 0.95% |
BEACONLIGHT CAPITAL, LLC | 208,546 | $3,011,000 | 0.91% |